The Pink Pill and New Therapies for Sexual Health



There are many new therapies for female sexual disorders and vaginal disorders which have been approved , including MonaLisa Touch. Other medical therapies are coming as well. The first medical therapy approved for pain with intercourse in menopausal women is Osphena. Testosterone has been tested in many forms, some of which are still in development stages and some look more promising than others, including,  testosterone patches, gels and intranasal (male intranasal just approved, Tefina still in studies, http://trimelpharmaceuticals.com/Products/Tefina-Overview) bremelanotide (in phase 3 studies,  http://www.palatin.com/products/bremelanotide.asp,hopefully coming within the next year or two), and then Flibanserin, being nick named the little pink pill ( hoping for approval in August http://news.yahoo.com/katie-couric-little-pink-pill-and-the-drugs-resubmission-for-fda-approval-031600521.html ) . The MonaLisa Touch therapy is a fractional CO2 vaginal therapy, http://www.cynosure.com/treatment/vaginal-health/that can treat sexual pain, vulvovaginal disorders such as atrophy. MonaLisa Touch can treat sexual dysfunction it can be used as an isolated therapy or in conjunction with current management strategies for these conditions. MonaLisa therapies will have beneficial effects on urogynecologic symptoms as well, including incontinence,
pelvic floor laxity, and burning. It  is a well tolerated, almost painless, procedure with few side effects. Indications are also for patients with the urogenital syndrome of menopause or from anti-estrogen therapies. There are also many uses for autologous platelet rich plasma on sexual function, including peri and intraclitoral and g-spot injection treatments which have been shown to enhance sexual function.
http://www. hadacm.comhadacm.com

Comments

Popular posts from this blog

Passing Your Uterine Lining, Menstrual Period Norms

Mirena IUD and Your Sex Drive

Post-Endometrial Ablation Syndrome